Brief: Engene Reports Second Quarter 2026 Financial Results And Provides Business Update
15/06/2026 14:15
BRIEF-Engene Reports Second Quarter 2026 Financial Results And Provides Business Update June 15 (Reuters) - enGene Therapeutics Inc ENGN.O:
ENGENE REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
ENGENE THERAPEUTICS - IMPLEMENTS WORKFORCE REDUCTION OF ABOUT 50% IN JUNE 2026
ENGENE THERAPEUTICS INC: CFO RYAN DAWS TO DEPART FROM CO, EFFECTIVE JULY 15, 2026
Source text: ID:nBw3w5vRfa
Further company coverage: ENGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on enGene Therapeutics
See all newsBrief: Engene Reports Second Quarter 2026 Financial Results And Provides Business Update
enGene Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Engene Holdings Inc - To Change Name To Engene Therapeutics Inc. Effective April 8, 2026
Brief: Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares
Brief: enGene Reports First Quarter 2026 Financial Results and Provides Business Update